Injectable Drug Delivery News

31. Stevanato Group Collaborates With Transcoject To Provide Pre-Fillable Syringe Polymer Options For Pharma 1/24/2023

    Stevanato Group S.p.A. a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced its latest collaboration with Transcoject GmbH, a medical device and pharma packaging solutions company.

32. Parenteral Drug Association Announces New EU GMP Annex 1 Implementation Interest Group 1/20/2023

    PDA is pleased to announce the formation of the Annex 1 Implementation Interest Group, which will begin meeting in February.

33. Argonaut Manufacturing Services Set To Expand Drug Product Fill/Finish Capabilities With Significant Capital Investment 1/10/2023

    Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the life sciences, molecular diagnostics, and biopharma industries, today announced a capital investment led by majority shareholder Telegraph Hill Partners that will be focused on expansion at their Carlsbad, CA, manufacturing facilities.

34. Oncorus Announces Research Collaboration With Daewoong Pharmaceutical For The Development Of Lipid Nanoparticle Formulations For mRNA Drug Candidates 1/4/2023

    Oncorus, Inc. (Nasdaq: ONCR), an RNA medicines company focused on developing intravenously administered, self-amplifying RNA to transform outcomes for cancer patients, and Daewoong Pharmaceutical Co., Ltd. (KRX: 069620), a leading South Korean pharmaceutical company, today announced a research collaboration for the discovery and development of novel lipid nanoparticle (LNP) formulations for mRNA drug candidates.

35. Berkshire Sterile Expands Analytical Testing And Development Services 12/19/2022

    Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish CDMO, recently purchased and validated three new analytical instruments to expand their testing and development capabilities.

36. Kindeva And Meridian Combine: Create Leading Drug-Device Combination Product CDMO 12/13/2022

    The combination has created a leading global contract development and manufacturing organization (“CDMO”) focused on drug-device combination products. The combination will operate under the Kindeva name, with Meridian operating as, “Meridian Medical Technologies, a Kindeva Company”.

37. Gov. Whitmer Announces Pfizer Investing $750M To Expand U.S. Sterile Injectable Facility, Create 300 Jobs 12/5/2022

    Today Governor Gretchen Whitmer announced that Pfizer Inc. will be investing $750M in its Kalamazoo, Michigan facility, expanding production and creating 300 good-paying jobs. This investment aims to establish the facility as one of the most technologically advanced in the world and continue to ensure the uninterrupted supply of Pfizer medicines and vaccines.

38. Datwyler Adds Steam Sterilization Option For Ready-To-Use Components For Injectable Drugs 12/1/2022

    Datwyler, a leading provider of high-quality, system-critical elastomer components, announces the launch of Steam Sterilization for Ready-to-Use components. This service is applicable to non-coated and coated solutions like OmniFlex® stoppers for vials and NeoFlexä plungers for prefilled syringes and cartridges. As part of the company’s “Quality First” approach to designing and producing these packaging components, Datwyler will deliver RTU components in robust packaging guaranteeing a shelf life of 2 years after steam sterilization.

39. WuXi STA Launches Another Parenteral Formulation Manufacturing Line At Wuxi City Site 12/1/2022

    WuXi STA, a subsidiary of WuXi AppTec, today announced a new parenteral formulation manufacturing line has started operation at the drug product site in Wuxi city, China. It is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units.

40. Recipharm Invests In Its Single Dose Nasal Platform Capabilities 11/30/2022

    Recipharm, a global contract development and manufacturing organisation (CDMO), has announced that it is expanding its capabilities for its proprietary Unidose Xtra (single dose) nasal delivery platform.